Amgen Inc. - Company & Market Research Reports

Home /
Companies /
Amgen Inc.

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 336
Immune Disorders Drugs 207
Biopharmaceuticals 176
Musculoskeletal Disorders Drugs 126
Genomics 116
Cardiovascular Drugs 104
Biotechnology 84
Pharmaceuticals 79
Drug Discovery 77
Endocrine and Metabolic Disorders Drugs 76
Biosimilars and Biosuperiors 72
Allergy and Immunology 67
Infusions and Injectables 65
Leukemia Drugs 63
Hematological Drugs 60
Clinical Trials 54
Oncology 52
Dermatological Drugs 51
Central Nervous System Drugs 49
Women's Health 45
Liver and Kidney Disorders Drugs 45
Needles and Syringes 42
Drug Delivery 38
Psoriasis Drugs 37
Diagnostics 36
Skin Cancer Drugs 35
Hematology 30
Infectious Diseases Drugs 28
Brain Cancer Drugs 28
Enzymes 27
Lung Cancer Drugs 26
Colon Cancer Drugs 26
Proteomics 26
Gastrointestinal Drugs 26
Analgesics 24
Immunosuppressive Drugs 24
Lymphoma Drugs 23
Dermatology 19
Pharmaceutical Manufacturing 19
Drugs by Therapeutic Area 18
Optical 17
Therapeutic Area 16
Respiratory Drugs 16
Urology and Nephrology 15
Healthcare Services 14
Kidney Cancer Drugs 14
Optical Disorders Drugs 13
Pancreatic Cancer Drugs 12
Nanomedicine 11
Generic Drugs 10
Breast Cancer Drugs 10
Prostate Cancer Drugs 10
Ovarian Cancer Drugs 10
Cervical Cancer Drugs 10
Cardiology 10
Sexual and Reproductive Health Drugs 10
E-Healthcare 9
Liver Cancer Drugs 8
Cancer Vaccines 8
Other Healthcare Facilities 8
Pulmonary Medicine 7
In Vitro Diagnostics 7
Biomarkers 7
Anti-Obesity Drugs 7
Gastroenterology 7
Neurology 6
Diabetes Drugs 6
Biomaterials 6
Vaccines 6
Mental Disorders Drugs 6
Company Reports 5
Animal Pharmaceuticals 5
Medical Devices 5
Molecular Diagnostics 5
Over the Counter (OTC) Drugs 5
Pediatrics 5
Asthma Drugs 5
Pharmaceutical Intermediates 4
Surgical Procedures 4
Thyroid Cancer Drugs 4
Alzheimer's Disease Drugs 4
Managed Care 3
Stem Cells 3
Endocrinology 3
Addiction Disorders Drugs 2
Bladder Cancer Drugs 2
Cardiovascular Devices 2
Infectious Disease Testing 2
Inhalers and Nebulisers 2
Mental Health 2
Uterine Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Antibiotics 2
Acne Drugs 2
Urological Disorders Drugs 2
Schizophrenia Drugs 2
Hepatology 1
Pharmacoeconomics 1
Fertility Services 1
Bioinformatics 1
Orthopedic Devices 1
Cholesterol Testing 1
Cough and Cold Drugs 1
Healthcare 1
Radiography 1
Transdermal and Transmucosal Drug Delivery 1
Blood Banking 1
Hospital Management 1
Respiratory Devices 1
Clinical Therapies 1
Clinical Skills 1
Palliative Care 1
Anatomy 1
Maternal and Neonatal Care 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

2,087 Results (Page 86 of 105)
- Relevance
  Sort by

Metastatic Cancer Drugs Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3932EUR$4,490USD£3,413GBP

Lymphoma Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
August 2023
96 Pages
Global

From

€3500EUR$4,281USD£3,144GBP

Blood Cancer Drugs Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3932EUR$4,490USD£3,413GBP

Precision Medicine Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3932EUR$4,490USD£3,413GBP

Gene Therapy Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3932EUR$4,490USD£3,413GBP

NEED HELP FINDING THE RIGHT PRODUCT? Craig will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Antibody Therapeutics Market Size, Share & Trends Analysis Report By Route of Administration (Intravenous, Subcutaneous, and Others), By Format, By Source, By End User, By Disease Areas, By Regional Outlook and Forecast, 2023 - 2030

 Report
January 2024
425 Pages
Global

From

€3153EUR$3,600USD£2,737GBP

Cell Regeneration Medicine Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3932EUR$4,490USD£3,413GBP

Secondary Hyperparathyroidism Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

 Report
February 2024
186 Pages
Global

From

€3941EUR$4,500USD£3,421GBP

Retinal Vein Occlusion Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3932EUR$4,490USD£3,413GBP

Proliferative Diabetic Retinopathy (PDR) Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3932EUR$4,490USD£3,413GBP

Cholesterylester Transfer Protein (CETP) Inhibitor - Pipeline Insight, 2025

 Clinical Trials
April 2025
90 Pages
Global

From

€1314EUR$1,500USD£1,140GBP

Head and Neck Cancer Therapeutics Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3932EUR$4,490USD£3,413GBP

Lumakras Drug Clinical Insight & Sales Forecast 2026

 Report
July 2021
60 Pages
Global

From

€1752EUR$2,000USD£1,520GBP

Age-Related Macular Degeneration Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3932EUR$4,490USD£3,413GBP

Melanoma Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type

 Report
June 2023
96 Pages
Global

From

€3500EUR$4,281USD£3,144GBP

Melanoma Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
June 2023
93 Pages
Global

From

€3500EUR$4,281USD£3,144GBP

Bi-Specific MAbS Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3932EUR$4,490USD£3,413GBP

Gastric Cancer Drugs Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3932EUR$4,490USD£3,413GBP

Intratumoral Cancer Therapies Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3932EUR$4,490USD£3,413GBP

PD-1 and PDL1 Inhibitors/ Immune Checkpoint Inhibitors Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3932EUR$4,490USD£3,413GBP

2,087 Results (Page 86 of 105)
- 1
- 84
- 85
- 86
- 87
- 88

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.